Consort Medical (LON:CSRT) subsidiary Bespak said today that it inked a development agreement with an undisclosed biopharmaceutical company for its Syrina auto-injector tech. The agreement says Bespak is responsible for early stage development of the auto-injector. If the undisclosed partner agrees to commercialize the developed product, both parties will enter into a full commercial supply agreement, […]
Consort Medical
AstraZeneca, Bespak ink deal for metered-dose inhaler
AstraZeneca (NYSE:AZN) said last week that it inked a multi-year commercial supply deal with Consort Medical (LON:CSRT) subsidiary Bespak for its pressurized metered-dose inhaler technology. Bespak will supply inhaler valves and actuators for use with AstraZeneca’s inhaled aerosol treatment for chronic obstructive pulmonary disease. AstraZeneca won FDA approval in April for the aerosol, Bevespi Aerosphere […]
Strong earnings help Consort Medical recover from hit by delay in Mylan approval
Consort Medical (LON:CSRT) said the impending launch of a generic Advair inhaler by Mylan (NSDQ:MYL) represents a significant opportunity for its Bespak drug delivery device unit, but analysts were less impressed after the FDA delayed its decision date for asthma therapy to March 28, 2017. That pushed CSRT shares down -1.9% to a $1.35 (941 pence) close yesterday on […]
Precision Ocular raises $19m, inks deal with Consort Medical for drug-device combo
Consort Medical said today it inked a development and manufacturing deal with Precision Ocular, and joined in a round of financing to support Precision Ocular, who raised $19 million (UK £13.5 million) total. The collaborative deal will leverage Consort subsidiaries Bespak and Aesica, with Bespak providing device development and manufacturing capabilities and Aesica offering manufacturing […]